Market revenue in 2022 | USD 339.5 million |
Market revenue in 2030 | USD 812.4 million |
Growth rate | 11.5% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 22.33% in 2024. Horizon Databook has segmented the Germany biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
Germany has a very robust and well-established industry manufacturing biopharma plastic-based medical products. According to the International Trade Administration, the country is the largest importer and exporter of biopharma plastics across the European Union.
The COVID-19 spread in Germany in 2020 drove the demand for biopharma plastic-based protective medical wear such as masks, gloves, and shoe covers. This led the government of the country to further increase its investments in the development of innovative healthcare technologies.
The adoption of novel technologies for offering superior quality and high-performance biopharma plastics for manufacturing durable and safe medical products is anticipated to boost the growth of the market in Germany from 2022 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into Germany biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account